{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:01:17Z","timestamp":1784768477599,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2025YFC2708301"],"award-info":[{"award-number":["2025YFC2708301"]}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"crossref","award":["2025ZD0545900 and 2025ZD0545902"],"award-info":[{"award-number":["2025ZD0545900 and 2025ZD0545902"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-026-04571-3","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T05:55:01Z","timestamp":1779861301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oncological and reproductive outcomes following fertility-preserving treatment in mismatch repair-deficient endometrial cancer or atypical endometrial hyperplasia"],"prefix":"10.1186","volume":"26","author":[{"given":"Tianyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rundong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kezhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9892-8795","authenticated-orcid":false,"given":"Jiaxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"1","key":"4571_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41572-021-00324-8","volume":"7","author":"V Makker","year":"2021","unstructured":"Makker V, MacKay H, Ray-Coquard I, et al. Endometrial cancer. Nat Rev Dis Primers. 2021;7(1):88. https:\/\/doi.org\/10.1038\/s41572-021-00324-8.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"4571_CR2","doi-asserted-by":"publisher","first-page":"444","DOI":"10.5468\/ogs.21116","volume":"64","author":"HI Ha","year":"2021","unstructured":"Ha HI, Chang HK, Park SJ, Lim J, Won YJ, Lim MC. The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999\u20132017: Korea Central Cancer Registry. Obstet Gynecol Sci. 2021;64(5):444\u201353. https:\/\/doi.org\/10.5468\/ogs.21116.","journal-title":"Obstet Gynecol Sci"},{"issue":"3","key":"4571_CR3","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ygyno.2009.05.038","volume":"114","author":"I Navarria","year":"2009","unstructured":"Navarria I, Usel M, Rapiti E, et al. Young patients with endometrial cancer: how many could be eligible for fertility-sparing treatment? Gynecol Oncol. 2009;114(3):448\u201351. https:\/\/doi.org\/10.1016\/j.ygyno.2009.05.038.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"4571_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00404-021-06380-5","volume":"306","author":"LK Nees","year":"2022","unstructured":"Nees LK, Heublein S, Steinmacher S, et al. Endometrial hyperplasia as a risk factor of endometrial cancer. Arch Gynecol Obstet. 2022;306(2):407\u201321. https:\/\/doi.org\/10.1007\/s00404-021-06380-5.","journal-title":"Arch Gynecol Obstet"},{"key":"4571_CR5","doi-asserted-by":"publisher","unstructured":"Ye J, Mm XQ, Qi X. Fertility-preserving treatment for endometrial atypical hyperplasia and endometrial cancer: a systematic review and meta-analysis. BMC Womens Health. 2026;26(1). https:\/\/doi.org\/10.1186\/s12905-026-04352-y.","DOI":"10.1186\/s12905-026-04352-y"},{"issue":"1","key":"4571_CR6","doi-asserted-by":"publisher","first-page":"hoac057","DOI":"10.1093\/hropen\/hoac057","volume":"2023","author":"A Rodolakis","year":"2023","unstructured":"Rodolakis A, Scambia G, Planchamp F, et al. ESGO\/ESHRE\/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma. Hum Reprod Open. 2023;2023(1):hoac057. https:\/\/doi.org\/10.1093\/hropen\/hoac057.","journal-title":"Hum Reprod Open"},{"key":"4571_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ygyno.2024.02.020","volume":"185","author":"N Agusti","year":"2024","unstructured":"Agusti N, Kanbergs A, Nitecki R. Potential of molecular classification to guide fertility-sparing management among young patients with endometrial cancer. Gynecol Oncol. 2024;185:121\u20137. https:\/\/doi.org\/10.1016\/j.ygyno.2024.02.020.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"4571_CR8","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.3802\/jgo.2023.34.e53","volume":"34","author":"Y Xue","year":"2023","unstructured":"Xue Y, Dong Y, Lou Y, et al. PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia. J Gynecol Oncol. 2023;34(4):e53. https:\/\/doi.org\/10.3802\/jgo.2023.34.e53.","journal-title":"J Gynecol Oncol"},{"issue":"3","key":"4571_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.ygyno.2021.03.029","volume":"161","author":"A Raffone","year":"2021","unstructured":"Raffone A, Catena U, Travaglino A, et al. Mismatch repair-deficiency specifically predicts recurrence of atypical endometrial hyperplasia and early endometrial carcinoma after conservative treatment: A multi-center study. Gynecol Oncol. 2021;161(3):795\u2013801. https:\/\/doi.org\/10.1016\/j.ygyno.2021.03.029.","journal-title":"Gynecol Oncol"},{"key":"4571_CR10","doi-asserted-by":"publisher","unstructured":"Chung YS, Woo HY, Lee JY et al. Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer. Am J Obstet Gynecol. 2021;224(4):370 e1- e13. https:\/\/doi.org\/10.1016\/j.ajog.2020.10.003.","DOI":"10.1016\/j.ajog.2020.10.003"},{"issue":"10","key":"4571_CR11","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1111\/1471-0528.14491","volume":"124","author":"M Zakhour","year":"2017","unstructured":"Zakhour M, Cohen JG, Gibson A, et al. Abnormal mismatch repair and other clinicopathologic predictors of poor response to progestin treatment in young women with endometrial complex atypical hyperplasia and well-differentiated endometrial adenocarcinoma: a consecutive case series. BJOG. 2017;124(10):1576\u201383. https:\/\/doi.org\/10.1111\/1471-0528.14491.","journal-title":"BJOG"},{"issue":"1","key":"4571_CR12","doi-asserted-by":"publisher","first-page":"100024","DOI":"10.1016\/j.ijgc.2024.100024","volume":"35","author":"LA De Vitis","year":"2025","unstructured":"De Vitis LA, Schivardi G, Delfrati S, et al. The prognostic impact of molecular classification in endometrial cancer that undergoes fertility-sparing treatment. Int J Gynecol Cancer. 2025;35(1):100024. https:\/\/doi.org\/10.1016\/j.ijgc.2024.100024.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"4571_CR13","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.3802\/jgo.2025.36.e59","volume":"36","author":"X Yang","year":"2025","unstructured":"Yang X, Xue Y, Shao W, et al. Fertility-sparing treatment outcomes using immune checkpoint inhibitors in endometrial cancer patients with Lynch syndrome. J Gynecol Oncol. 2025;36(4):e59. https:\/\/doi.org\/10.3802\/jgo.2025.36.e59.","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"4571_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/annonc\/mdv484","volume":"27","author":"N Colombo","year":"2016","unstructured":"Colombo N, Creutzberg C, Amant F, et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Ann Oncol. 2016;27(1):16\u201341. https:\/\/doi.org\/10.1093\/annonc\/mdv484.","journal-title":"Ann Oncol"},{"issue":"5","key":"4571_CR15","doi-asserted-by":"publisher","first-page":"e71875","DOI":"10.1002\/cam4.71875","volume":"15","author":"XQ Qian","year":"2026","unstructured":"Qian XQ, Fu HH, Wan XY, Hu DX, Shen YM. Efficacy of Fertility-Sparing Treatment With Progestin Is Associated With Different Molecular Classification in Endometrial Carcinoma and Atypical Endometrial Hyperplasia. Cancer Med. 2026;15(5):e71875. https:\/\/doi.org\/10.1002\/cam4.71875.","journal-title":"Cancer Med"},{"issue":"5","key":"4571_CR16","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/cncr.30496","volume":"123","author":"A Talhouk","year":"2017","unstructured":"Talhouk A, McConechy MK, Leung S, et al. Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer. Cancer. 2017;123(5):802\u201313. https:\/\/doi.org\/10.1002\/cncr.30496.","journal-title":"Cancer"},{"issue":"5","key":"4571_CR17","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","volume":"29","author":"S Kommoss","year":"2018","unstructured":"Kommoss S, McConechy MK, Kommoss F, et al. Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series. Ann Oncol. 2018;29(5):1180\u20138. https:\/\/doi.org\/10.1093\/annonc\/mdy058.","journal-title":"Ann Oncol"},{"key":"4571_CR18","doi-asserted-by":"publisher","first-page":"154278","DOI":"10.1016\/j.prp.2022.154278","volume":"241","author":"X Zhang","year":"2023","unstructured":"Zhang X, Chen D, Zhao X, et al. Application of molecular classification to guiding fertility-sparing therapy for patients with endometrial cancer or endometrial intraepithelial neoplasia. Pathol Res Pract. 2023;241:154278. https:\/\/doi.org\/10.1016\/j.prp.2022.154278.","journal-title":"Pathol Res Pract"},{"key":"4571_CR19","doi-asserted-by":"publisher","first-page":"810631","DOI":"10.3389\/fonc.2022.810631","volume":"12","author":"X Ran","year":"2022","unstructured":"Ran X, Hu T, Li Z. Molecular Classification in Patients With Endometrial Cancer After Fertility-Preserving Treatment: Application of ProMisE Classifier and Combination of Prognostic Evidence. Front Oncol. 2022;12:810631. https:\/\/doi.org\/10.3389\/fonc.2022.810631.","journal-title":"Front Oncol"},{"issue":"8","key":"4571_CR20","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1111\/aogs.14815","volume":"103","author":"S Zhao","year":"2024","unstructured":"Zhao S, Zhang J, Yan Y, et al. Oncological and reproductive outcomes of endometrial atypical hyperplasia and endometrial cancer patients undergoing conservative therapy with hysteroscopic resection: A systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2024;103(8):1498\u2013512. https:\/\/doi.org\/10.1111\/aogs.14815.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"4571_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/humupd\/dmab041","volume":"28","author":"E Herrera Cappelletti","year":"2022","unstructured":"Herrera Cappelletti E, Humann J, Torrejon R, Gambadauro P. Chances of pregnancy and live birth among women undergoing conservative management of early-stage endometrial cancer: a systematic review and meta-analysis. Hum Reprod Update. 2022;28(2):282\u201395. https:\/\/doi.org\/10.1093\/humupd\/dmab041.","journal-title":"Hum Reprod Update"},{"issue":"37","key":"4571_CR22","doi-asserted-by":"publisher","first-page":"e8034","DOI":"10.1097\/MD.0000000000008034","volume":"96","author":"J Wei","year":"2017","unstructured":"Wei J, Zhang W, Feng L, Gao W. Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: A meta-analysis and systematic review. Med (Baltim). 2017;96(37):e8034. https:\/\/doi.org\/10.1097\/MD.0000000000008034.","journal-title":"Med (Baltim)"},{"issue":"4","key":"4571_CR23","doi-asserted-by":"publisher","first-page":"e2661","DOI":"10.1016\/j.ajog.2012.08.011","volume":"207","author":"ID Gallos","year":"2012","unstructured":"Gallos ID, Yap J, Rajkhowa M, Luesley DM, Coomarasamy A, Gupta JK. Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol. 2012;207(4):e2661\u201312. https:\/\/doi.org\/10.1016\/j.ajog.2012.08.011.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"4571_CR24","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.1016\/j.ajog.2012.05.012","volume":"207","author":"K Upson","year":"2012","unstructured":"Upson K, Allison KH, Reed SD, et al. Biomarkers of progestin therapy resistance and endometrial hyperplasia progression. Am J Obstet Gynecol. 2012;207(1):e361\u20138. https:\/\/doi.org\/10.1016\/j.ajog.2012.05.012.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"4571_CR25","first-page":"881","volume":"62","author":"D Dai","year":"2002","unstructured":"Dai D, Wolf DM, Litman ES, White MJ, Leslie KK. Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors. Cancer Res. 2002;62(3):881\u20136.","journal-title":"Cancer Res"},{"key":"4571_CR26","doi-asserted-by":"publisher","unstructured":"Bostan IS, Mihaila M, Roman V, et al. Landscape of Endometrial Cancer: Molecular Mechanisms, Biomarkers, and Target Therapy. Cancers (Basel). 2024;16(11). https:\/\/doi.org\/10.3390\/cancers16112027.","DOI":"10.3390\/cancers16112027"},{"issue":"2","key":"4571_CR27","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/ijgo.14969","volume":"164","author":"Y Yang","year":"2024","unstructured":"Yang Y, Wu SF, Bao W. Molecular subtypes of endometrial cancer: Implications for adjuvant treatment strategies. Int J Gynaecol Obstet. 2024;164(2):436\u201359. https:\/\/doi.org\/10.1002\/ijgo.14969.","journal-title":"Int J Gynaecol Obstet"},{"key":"4571_CR28","doi-asserted-by":"publisher","first-page":"1010490","DOI":"10.3389\/fimmu.2022.1010490","volume":"13","author":"D Cao","year":"2022","unstructured":"Cao D, Gao Y, Zhang RX, et al. Case report: Reproductive organ preservation and subsequent pregnancy for an infertility patient with lynch syndrome-associated synchronous endometrial cancer and colon cancer after treatment with a PD-1 checkpoint inhibitor. Front Immunol. 2022;13:1010490. https:\/\/doi.org\/10.3389\/fimmu.2022.1010490.","journal-title":"Front Immunol"},{"issue":"1","key":"4571_CR29","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/aog.0b013e31827a0643","volume":"121","author":"JY Park","year":"2013","unstructured":"Park JY, Seong SJ, Kim TJ, et al. Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer. Obstet Gynecol. 2013;121(1):136\u201342. https:\/\/doi.org\/10.1097\/aog.0b013e31827a0643.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"4571_CR30","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.fertnstert.2013.11.028","volume":"101","author":"M Koskas","year":"2014","unstructured":"Koskas M, Uzan J, Luton D, Rouzier R, Darai E. Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis. Fertil Steril. 2014;101(3):785\u201394. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.11.028.","journal-title":"Fertil Steril"},{"key":"4571_CR31","doi-asserted-by":"publisher","first-page":"1506639","DOI":"10.3389\/fonc.2025.1506639","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Lai T, Chu D, Bai J, Yan S, Guo R. The association of molecular classification with fertility-sparing treatment of atypical endometrial hyperplasia and endometrial cancer: a retrospective study. Front Oncol. 2025;15:1506639. https:\/\/doi.org\/10.3389\/fonc.2025.1506639.","journal-title":"Front Oncol"},{"key":"4571_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ejogrb.2024.09.006","volume":"302","author":"T Zhang","year":"2024","unstructured":"Zhang T, Zhang X, Peng P, Yang J. Fertility-sparing treatment in MSI-H\/MMRd endometrial carcinoma or atypical endometrial hyperplasia: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2024;302:177\u201383. https:\/\/doi.org\/10.1016\/j.ejogrb.2024.09.006.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"4571_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5653\/cerm.2023.06814","volume":"53","author":"A Seol","year":"2026","unstructured":"Seol A, Jeong HG, Kim S, Lee S. Fertility-sparing treatments for patients with endometrial cancer: A comprehensive review. Clin Exp Reprod Med. 2026;53(1):1\u20139. https:\/\/doi.org\/10.5653\/cerm.2023.06814.","journal-title":"Clin Exp Reprod Med"},{"key":"4571_CR34","doi-asserted-by":"publisher","unstructured":"Billone V, Gullo G, Conti E, et al. Minilaparoscopic Versus Conventional Laparoscopic Hysterectomy: Insights from a Single-Center Retrospective Cohort Study with Legal Considerations. Med (Kaunas). 2025;61(7). https:\/\/doi.org\/10.3390\/medicina61071216.","DOI":"10.3390\/medicina61071216"},{"key":"4571_CR35","doi-asserted-by":"publisher","unstructured":"Piergentili R, Gullo G, Basile G, et al. Circulating miRNAs as a Tool for Early Diagnosis of Endometrial Cancer-Implications for the Fertility-Sparing Process: Clinical, Biological, and Legal Aspects. Int J Mol Sci. 2023;24(14). https:\/\/doi.org\/10.3390\/ijms241411356.","DOI":"10.3390\/ijms241411356"},{"issue":"1","key":"4571_CR36","doi-asserted-by":"publisher","first-page":"20251144","DOI":"10.1515\/med-2025-1144","volume":"20","author":"L De Paola","year":"2025","unstructured":"De Paola L, Napoletano G, Gullo G, Circosta F, Montanari Vergallo G, Marinelli S. The era of increasing cancer survivorship: Trends in fertility preservation, medico-legal implications, and ethical challenges. Open Med (Wars). 2025;20(1):20251144. https:\/\/doi.org\/10.1515\/med-2025-1144.","journal-title":"Open Med (Wars)"},{"key":"4571_CR37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ygyno.2024.04.013","volume":"186","author":"H Peng","year":"2024","unstructured":"Peng H, Jiang J, Li L, et al. Mismatch repair deficiency and abnormal p53 expression has significant predictive value for progesterone resistance and endometrial tumorigenesis in patients with endometrial atypical hyperplasia receiving fertility-preserving treatment. Gynecol Oncol. 2024;186:154\u201360. https:\/\/doi.org\/10.1016\/j.ygyno.2024.04.013.","journal-title":"Gynecol Oncol"},{"key":"4571_CR38","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ygyno.2023.11.006","volume":"179","author":"C Dagher","year":"2023","unstructured":"Dagher C, Manning-Geist B, Ellenson LH, et al. Molecular subtyping in endometrial cancer: A promising strategy to guide fertility preservation. Gynecol Oncol. 2023;179:180\u20137. https:\/\/doi.org\/10.1016\/j.ygyno.2023.11.006.","journal-title":"Gynecol Oncol"},{"key":"4571_CR39","doi-asserted-by":"publisher","first-page":"948509","DOI":"10.3389\/fmed.2022.948509","volume":"9","author":"U Catena","year":"2022","unstructured":"Catena U, Della Corte L, Raffone A, et al. Fertility-sparing treatment for endometrial cancer and atypical endometrial hyperplasia in patients with Lynch Syndrome: Molecular diagnosis after immunohistochemistry of MMR proteins. Front Med (Lausanne). 2022;9:948509. https:\/\/doi.org\/10.3389\/fmed.2022.948509.","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"4571_CR40","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3760\/cma.j.cn112141-20220628-00419","volume":"57","author":"YQ Wang","year":"2022","unstructured":"Wang YQ, Kang N, Li LW, et al. Significance of molecular classification in fertility-sparing treatment of endometrial carcinoma and atypical endometrial hyperplasia. Zhonghua fu chan ke za zhi. 2022;57(9):692\u2013700. https:\/\/doi.org\/10.3760\/cma.j.cn112141-20220628-00419.","journal-title":"Zhonghua fu chan ke za zhi"},{"key":"4571_CR41","doi-asserted-by":"publisher","first-page":"1286724","DOI":"10.3389\/fendo.2023.1286724","volume":"14","author":"P Wu","year":"2023","unstructured":"Wu P, Shan W, Xue Y, et al. Impacts of ovarian reserve on conservative treatment for endometrial cancer and atypical hyperplasia. Front Endocrinol (Lausanne). 2023;14:1286724. https:\/\/doi.org\/10.3389\/fendo.2023.1286724.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4571_CR42","doi-asserted-by":"publisher","first-page":"1630301","DOI":"10.3389\/fonc.2025.1630301","volume":"15","author":"J Liu","year":"2025","unstructured":"Liu J, Zheng Y, Liu J. Fertility preservation and assisted reproductive strategies in endometrial cancer patients with lynch syndrome. Front Oncol. 2025;15:1630301. https:\/\/doi.org\/10.3389\/fonc.2025.1630301.","journal-title":"Front Oncol"},{"key":"4571_CR43","doi-asserted-by":"publisher","unstructured":"Listorti I, Manzo R, Arrivi C, et al. PGT-M, a Useful Tool to Manage the Lynch Syndrome Transmission. Int J Mol Sci. 2023;24(22). https:\/\/doi.org\/10.3390\/ijms242216114.","DOI":"10.3390\/ijms242216114"},{"issue":"1","key":"4571_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/17446651.2025.2596680","volume":"21","author":"L Marin","year":"2026","unstructured":"Marin L, Vural NA, Oktay KH. Advances to fertility preservation in patients with gynecological cancers. Expert Rev Endocrinol Metab. 2026;21(1):43\u201352. https:\/\/doi.org\/10.1080\/17446651.2025.2596680.","journal-title":"Expert Rev Endocrinol Metab"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-026-04571-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04571-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04571-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:05:58Z","timestamp":1784765158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12905-026-04571-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4571"],"URL":"https:\/\/doi.org\/10.1186\/s12905-026-04571-3","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by the Ethics Committee of Peking Union Medical College Hospital (IRB number: I-25PJ3197). All the patients signed the informed consent form, and all procedures were carried out following the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"377"}}